Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Mukesh Ambani speech at RIL AGM: Full text

2018-07-05 livemint
Reliance Industries Ltd (RIL) chairman Mukesh Ambani announced the launch of Jio GigaFiber service at its 41st annual general meeting (AGM) in Mumbai.
500325 RELIANCE RIGD MODERN 503015 RLNIY

0
Reliance Industries 41st AGM: Full text of speech by Mukesh Ambani

2018-07-05 moneycontrol
At Reliance Industries 41'st AGM since listing, RIL chairman Mukesh Ambani talked about the company's achievements, key initiatives and future plans. He also launched advanced fiber-based broadband connectivity service called JioGigaFibre.
500325 RELIANCE RIGD MODERN 503015 RLNIY

0
INTERVIEW | After 21 mln tn capacity, SAIL aims to achieve 50 in 15 years with zero sales of semis: Chairman PK Singh

2018-06-05 moneycontrol
PK Singh has an onerous task. As Steel Authority of India Chairman, he steers many of India’s first Prime Minister Jawaharlal Nehru’s Temples of Modern India – the Rourkela, Bhilai, Durgapur, Bokaro and Burnpur steel plants. But in the marketplace, leadership is more an outcome of business acumen than history. It is this understanding that has helped Singh as he attempts to put a little bit of SAIL (back) in everybody’s life.
MODERN 503015

0
Ambedkar Jayanti 2018: 15 facts about the Founding Father of Modern India

2018-04-14 freepressjournal.in
Bhimrao Ramji Ambedkar, fondly known as Babasaheb, was an Indian jurist, economist, politician and social reformer who campaigned against social discrimination of Dalits in the Indian society. He was the principal architect of India’s Constitution and India’s first law minister. Born on April 14, 1891 to Bhimabai Sakpal and Ramji Maloji Sakpal in Madhya Pradesh, he was a multi-faceted personality who fought against the caste system and socio-economic deprivation.
MODERN 503015

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...